Development of the drug efficacy testing in ex vivo 3D cultures (DETECT) platform and its application to functional precision medicine in ovarian cancer

被引：0
|
作者：
Akerlund, Emma [1 ]
Gudoityte, Greta [1 ]
Lamodiere, Elisabeth Moussaud [1 ]
Carlson, Joseph [2 ]
Wallin, Emelie [2 ]
Fernebro, Josefin [2 ]
Kallioniemi, Olli [1 ]
Ostling, Paivi [1 ]
Joneborg, Ulrika [2 ]
Seashore-Ludlow, Brinton [1 ]
机构：
[1] Karolinska Inst, Sci Life Lab, Stockholm, Sweden
[2] Karolinska Inst, Stockholm, Sweden
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1890
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The drug efficacy testing in 3D cultures platform identifies effective drugs for ovarian cancer patients
    Akerlund, Emma
    Gudoityte, Greta
    Moussaud-Lamodiere, Elisabeth
    Lind, Olina
    Bwanika, Henri Colyn
    Lehti, Kaisa
    Salehi, Sahar
    Carlson, Joseph
    Wallin, Emelie
    Fernebro, Josefin
    Ostling, Paivi
    Kallioniemi, Olli
    Joneborg, Ulrika
    Seashore-Ludlow, Brinton
    [J]. NPJ PRECISION ONCOLOGY, 2023, 7 (01)
  • [2] The drug efficacy testing in 3D cultures platform identifies effective drugs for ovarian cancer patients
    Emma Åkerlund
    Greta Gudoityte
    Elisabeth Moussaud-Lamodière
    Olina Lind
    Henri Colyn Bwanika
    Kaisa Lehti
    Sahar Salehi
    Joseph Carlson
    Emelie Wallin
    Josefin Fernebro
    Päivi Östling
    Olli Kallioniemi
    Ulrika Joneborg
    Brinton Seashore-Ludlow
    [J]. npj Precision Oncology, 7
  • [3] Ovarian cancer ex vivo 3D tumor cultures predict patient specific drug sensitivity
    Grillet, Fanny
    Jariani, Abbas
    Overkamp, Juul
    Daszkiewicz, Lidia
    Yan, Kuan
    Price, Leo S.
    Vader, Willemijn
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [4] 3D EX VIVO PATIENT TISSUE PLATFORM FOR IMMUNOONCOLOGY DRUG TESTING
    Basten, Sander
    Beztsinna, Nataliia
    Grillet, Fanny
    Yan, Kuan
    Meesters, Niels
    van der Meer, Donny
    Spanjaard, Emma
    Vader, Willemijn
    Price, Leo
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A212 - A212
  • [5] Ex vivo drug sensitivity testing of primary cells for precision cancer medicine
    Kuznetsov, Sergey G.
    Ianevski, Alexander
    Kulessky, Evgeny
    Laamanen, Karoliina
    Lehtinen, Elina
    Nurmi, Maria
    Potdar, Swapnil
    Saarela, Jani
    Suomi, Katja
    Turunen, Laura
    Wennerberg, Krister
    Tammela, Paivi
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [6] Establishment of a 3D ex-vivo assay as a preclinical drug testing platform for personalized cancer therapy
    Dhar, Sumeer
    Chiovaro, Francesca
    Tanos, Tamara
    Hejhal, Tomas
    Heilemariam, Seife
    Kelm, Jens
    Irmisch, Anja
    Levesque, Mitchell
    [J]. CANCER RESEARCH, 2017, 77
  • [7] Development of an Ex Vivo 3D Functional Assay for Novel Drug Discoveries
    Murali, Vasanth Siruvallur
    Danuser, Gaudenz
    Cobanoglu, Murat Can
    [J]. JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [8] Patient specific drug sensitivity to novel treatment approaches in ovarian cancer ex vivo 3D tumor cultures
    Grillet, Fanny
    Jariani, Abbas
    Overkamp, Juul
    Daszkiewicz, Lidia
    Yan, Kuan
    Price, Leo
    Vader, Willemijn
    [J]. MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [9] Pancreatic cancer 3D organoids: a co-clinical platform for translational research and ex vivo drug testing
    Hussung, S.
    Koehler, K.
    Koehne, N.
    Michalczyk, S.
    Mastroianni, J.
    Fritsch, K.
    Zeiser, R.
    Boerries, M.
    Wittel, U.
    Fritsch, R.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 237 - 237
  • [10] Multivariate analysis of ex vivo kidney 3D immune-microtumors for functional precision medicine
    Peerani, Eleonora
    Nan, Keqian
    Wiskerke, Demi A.
    Richardson, Thomas D.
    Maximchick, Polina
    Kearney, Jay
    de Fraine, George R.
    Loughrey, Kerrie L.
    Ient, Jonathan
    Hudson, Jessica A.
    Kaffa, Andreas
    Crawley, Aston M.
    Bah, Nourdine K.
    Molina, Edgar G. Lopez
    Tham, Elli
    Iori, Francesco
    Williams, Matthew H.
    Tran, Maxine G.
    Ranatunga, Duleek N.
    [J]. CANCER RESEARCH, 2024, 84 (06)
12345